Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

Clinical trial NCT00220727 · COMPLETED

Trial details

NCT number: NCT00220727
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic

Start date: 2003-07-01
Primary completion: 2003-10-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.